Skip to main content
logo
Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
10.87
+0.32 (3.08%)
Sep 14, 2026, 3:23 PM EDT - Market open

Candel Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
8323103694352224
Market Cap Growth
212.41%-15.87%767.25%-17.80%-76.95%-
Enterprise Value
68023036822-3137
Last Close Price
10.545.658.681.471.797.82

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
----413.761794.84
PB Ratio
6.365.975.563.341.083.50
P/TBV Ratio
6.595.975.563.341.083.50

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-----1092.09

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.390.940.201.790.480.01
Net Debt / Equity Ratio
-1.20-1.36-1.34-0.99-0.99-1.28
Net Debt / EBITDA Ratio
2.131.492.760.341.393.22
Net Debt / FCF Ratio
2.651.823.300.371.443.41
Asset Turnover
----0.000.00
Quick Ratio
15.8913.312.742.5012.4815.41
Current Ratio
16.0913.492.772.5912.8115.84
Return on Equity (ROE)
-81.84%-64.58%-139.56%-125.50%-33.61%-80.60%
Return on Assets (ROA)
-28.64%-25.95%-28.14%-39.95%-26.01%-25.22%
Return on Capital Employed (ROCE)
-36.80%-41.50%-48.10%-140.70%-48.20%-30.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-10.65%-12.31%-14.97%-89.24%-36.34%-16.10%
FCF Yield
-6.90%-12.54%-7.33%-81.63%-63.26%-10.72%
Buyback Yield / Dilution
-45.29%-67.19%-9.47%-0.39%-52.72%-62.49%
SEC Filings: 10-K · 10-Q